(Press-News.org) A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.
The study used a mouse model of menopause to show that an injection of a polyclonal antipeptide antibody enhances bone regeneration by simultaneously slowing bone destruction and building bone, say researchers at the Mount Sinai School of Medicine, New York. In addition, the monoclonal antibody is likely to be safer because it is cleared from the blood and is not retained in bone.
Results from the study are published online August 20 in the journal Proceedings of the National Academy of Sciences.
"Bone loss in women begins very early, at least two to three years before a woman's last period and within eight to ten years, a woman will lose 50% of her lifetime bone loss," says the study's senior investigator, Mone Zaidi, MD, Professor of Medicine and of Structural and Chemical Biology, at Mount Sinai School of Medicine in New York." It occurs painlessly, without notice up to a point where women fracture."
Zaidi, who is director, of the Mount Sinai Bone Program, at Mount Sinai School of Medicine, New York, is the senior investigator of the research that developed the polyclonal antipeptide antibody to FSH and tested it in mice whose ovaries were removed. Peptides are short chains of amino acids, and the FSH antibody is a highly specific antibody.
"A few years ago, we showed that FSH [follicle stimulating hormone] directly regulates bone by bypassing the estrogen axis," says Zaidi. FSH rises early in menopause, stimulates bone removal and negatively regulates bone formation. "By blocking FSH with the FSH-specific polyclonal antibody, we were able to block bone resorption by osteoclasts [cells that break down bone] and stimulate bone formation through osteoblasts cells [cells that build bone]."
Zaidi summed up the research team's goal: "Our aim is to find a way to prevent osteoporosis rather than simply treat established disease using medicines that are well tolerated. We believe that a future humanized monoclonal antibody to FSH is likely to be safer than existing treatments because it will not reside in the bone."
###The National Institutes of Health, the U.S. Department of Veterans Affairs, and the U.S. Department of Agriculture supported the research.
Other senior Mount Sinai researchers involved in the study were Terry F. Davies, MD, Li Sun, MD, and Maria New, MD.
Researchers at the Mount Sinai Bone Program have made groundbreaking discoveries in understanding bone remodeling and developing new treatments for osteoporosis, estimated to affect 50 million women worldwide. Recently, the group has discovered the pituitary bone axis, which has revolutionized the paradigm for understanding osteoporosis.
The Mount Sinai Bone Program was established in 1999 with Dr. Zaidi as its Founding Director. It is recognized nationally and internationally for its cutting-edge translational research and highly sought after clinical work in osteoporosis and other bone diseases, including rare genetic diseases, such as Gaucher Disease. It is supported by the National Institutes of Health.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of the leading medical schools in the United States. The Medical School is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Of the top 20 hospitals in the United States, Mount Sinai is one of 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.
For more information, visit http://www.mountsinai.org/.
Find Mount Sinai on:
Facebook: http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy
Dual action polyclonal antibody may offer more effective, safer protection against osteoporosis
2012-08-21
ELSE PRESS RELEASES FROM THIS DATE:
Teaching a microbe to make fuel
2012-08-21
CAMBRIDGE, MA -- A humble soil bacterium called Ralstonia eutropha has a natural tendency, whenever it is stressed, to stop growing and put all its energy into making complex carbon compounds. Now scientists at MIT have taught this microbe a new trick: They've tinkered with its genes to persuade it to make fuel — specifically, a kind of alcohol called isobutanol that can be directly substituted for, or blended with, gasoline.
Christopher Brigham, a research scientist in MIT's biology department who has been working to develop this bioengineered bacterium, is currently ...
Vitamin D supplementation can decrease risk of respiratory infections in children
2012-08-21
A study conducted in Mongolian schoolchildren supports the possibility that daily vitamin D supplementation can reduce the risk of respiratory infections in winter. In a report that will appear in the journal Pediatrics and has received early online release, an international research team found that vitamin D supplementation decreased the risk of respiratory infections among children who had low blood levels of vitamin D at the start of the study.
"Our randomized controlled trial shows that vitamin D has important effects on infection risk," says Carlos Camargo, MD, ...
Patterning defect-free nanocrystal films with nanometer resolution
2012-08-21
Films made of semiconductor nanocrystals — tiny crystals measuring just a few billionths of a meter across — are seen as a promising new material for a wide range of applications. Nanocrystals could be used in electronic or photonic circuits, detectors for biomolecules, or the glowing pixels on high-resolution display screens. They also hold promise for more efficient solar cells.
The size of a semiconductor nanocrystal determines its electrical and optical properties. But it's very hard to control the placement of nanocrystals on a surface in order to make structurally ...
Politics and prejudice -- insights from Psychological Science
2012-08-21
New research from Psychological Science explores factors operating in political attitudes that could explain why political ideology and prejudice are often linked.
Liberals and Conservatives Both Prejudiced Against Groups with Opposing Values
Research has associated political conservatism with prejudice toward various stereotyped groups. But research has also shown that people select and interpret evidence consistent with their own pre-existing attitudes and ideologies. In this article, Chambers and colleagues hypothesized that, contrary to what some research might ...
Scientist finds new way to predict heat layer troublemaker
2012-08-21
Researchers at a recent worldwide conference on fusion power have confirmed the surprising accuracy of a new model for predicting the size of a key barrier to fusion that a top scientist at the U.S. Department of Energy's Princeton Plasma Physics Laboratory (PPPL) has developed. The model could serve as a starting point for overcoming the barrier. "This allows you to depict the size of the challenge so you can think through what needs to be done to overcome it," said physicist Robert Goldston, the Princeton University professor of astrophysical sciences and former PPPL ...
Specific toxic byproduct of heat-processed food may lead to increased body weight and diabetes
2012-08-21
Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes. The findings are published in the August 20, 2012 issue of the Proceedings of the National Academy of Sciences.
The research team, led by Helen Vlassara, MD, Professor and Director of the Division of Experimental Diabetes and Aging, found that mice with sustained exposure to the compound, methyl-glyoxal (MG), developed significant abdominal weight gain, early insulin ...
UCSB scientists examine effects of manufactured nanoparticles on soybean crops
2012-08-21
(Santa Barbara, Calif.) –– Sunscreens, lotions, and cosmetics contain tiny metal nanoparticles that wash down the drain at the end of the day, or are discharged after manufacturing. Those nanoparticles eventually end up in agricultural soil, which is a cause for concern, according to a group of environmental scientists that recently carried out the first major study of soybeans grown in soil contaminated by two manufactured nanomaterials (MNMs).
The team was led by scientists at UC Santa Barbara's Bren School of Environmental Science & Management. The team is also affiliated ...
Information overload in the era of 'big data'
2012-08-21
Botany is plagued by the same problem as the rest of science and society: our ability to generate data quickly and cheaply is surpassing our ability to access and analyze it. In this age of big data, scientists facing too much information rely on computers to search large data sets for patterns that are beyond the capability of humans to recognize—but computers can only interpret data based on the strict set of rules in their programming.
New tools called ontologies provide the rules computers need to transform information into knowledge, by attaching meaning to data, ...
Stroke disrupts how brain controls muscle synergies
2012-08-21
CAMBRIDGE, MA -- The simple act of picking up a pencil requires the coordination of dozens of muscles: The eyes and head must turn toward the object as the hand reaches forward and the fingers grasp it. To make this job more manageable, the brain's motor cortex has implemented a system of shortcuts. Instead of controlling each muscle independently, the cortex is believed to activate muscles in groups, known as "muscle synergies." These synergies can be combined in different ways to achieve a wide range of movements.
A new study from MIT, Harvard Medical School and the ...
Nanoparticles added to platelets double internal injury survival rate
2012-08-21
Nanoparticles tailored to latch onto blood platelets rapidly create healthy clots and nearly double the survival rate in the vital first hour after injury, new research shows.
"We knew an injection of these nanoparticles stopped bleeding faster, but now we know the bleeding is stopped in time to increase survival following trauma," said Erin Lavik, a professor of biomedical engineering at Case Western Reserve University and leader of the effort.
The researchers are developing synthetic platelets that first responders and battlefield medics could carry with them to stabilize ...